(MENAFN- EIN Presswire) Inhaled Nitric Oxide Market size, share
Exploring the Current Landscape and Future Opportunities of Inhaled Nitric Oxide Market: Trends, Challenges, and Technological Advancements
PORTLAND, OREGON, UNITED STATES, March 29, 2023 /einpresswire.com / -- Inhaled nitric oxide has emerged as a promising therapeutic option for respiratory diseases, and the market for this innovative treatment has been growing steadily. According to recent market research, the inhaled nitric oxide market size was valued at $634.4 million in 2019, and it is expected to witness significant growth in the coming years. The market is projected to reach $1,180.98 million by 2027, registering a healthy CAGR of 8.1% from 2020 to 2027. This growth can be attributed to the increasing incidence of respiratory disorders, including acute respiratory distress syndrome, chronic obstructive pulmonary disease, and pulmonary hypertension, among others. The rise in neonatal respiratory distress syndrome and the growing demand for nitric oxide therapy in critical care units are also expected to fuel the market growth. Additionally, the expanding applications of inhaled nitric oxide in pharmaceutical manufacturing and the ongoing clinical trials exploring its potential uses in various disease conditions are likely to contribute to the growth of the inhaled nitric oxide market in the near future.
Download PDF Brochure at:
inhaled nitric oxide has antiviral properties and improved oxygenation. Therefore, nitric oxide is now being tested as an experimental treatment for COVID-19. It is helpful in protecting healthcare workers on the front line of the pandemic from getting sick. Further, iNO is used for the treatment of pulmonary hypertension, ARDS, and other respiratory diseases, whereas several undergoing randomized clinical trials are being conducted to investigate the role of inhaled nitric oxide in COVID-19. Moreover, key players such as Mallinckrodt have also initiated a retrospective study for the use of iNO in COVID-19 patients. Moreover, multiple ongoing clinical trials are conducted for iNO as a treatment for COVID-19 and it is being used with promising results in the patient population.
The key players profiled in this report include
1.Air Liquide S.A
2.Bellerophon Therapeutics
3.BOC Healthcare
4.Beyond Air
5.Halma
6.Linde
7.Mallinckrodt
8.Novoteris
9.VERO Biotech
10.Nu-Med Plus.
Inhaled Nitric Oxide Market Report Highlights
The inhaled nitric oxide market has been growing steadily in recent years, driven by the increasing prevalence of respiratory diseases and the growing demand for effective therapies. The market is segmented based on application and region.
By application, the inhaled nitric oxide market is segmented into neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and others. Among these, neonatal respiratory treatment is expected to hold the largest market share due to the rising incidence of neonatal respiratory distress syndrome (NRDS) and the increasing demand for nitric oxide therapy in neonatal intensive care units (NICUs).
COPD is also a significant segment of the inhaled nitric oxide market due to the high prevalence of the disease worldwide. Inhaled nitric oxide therapy has been shown to be effective in reducing pulmonary hypertension and improving oxygenation in patients with COPD.
ARDS is another significant application segment, with inhaled nitric oxide therapy being used to improve oxygenation in critically ill patients with the condition.
By region, the inhaled nitric oxide market is segmented into North America, Europe, Asia-Pacific, and the rest of the world. North America is expected to hold the largest market share due to the high prevalence of respiratory diseases and the availability of advanced healthcare infrastructure in the region. Europe is also a significant market for inhaled nitric oxide due to the increasing demand for effective respiratory therapies and the presence of major market players in the region.
Asia-Pacific is expected to witness significant growth in the inhaled nitric oxide market due to the rising prevalence of respiratory diseases and the increasing investment in healthcare infrastructure in the region.
FREQUENTLY ASKED QUESTIONS?
1.What is inhaled nitric oxide, and how does it work in the body?
2.What are the medical conditions that inhaled nitric oxide is used to treat, and how effective is it?
3.What are the potential side effects and risks associated with using inhaled nitric oxide?
4.How is inhaled nitric oxide administered, and what is the typical dosage?
5.What is the current market size for inhaled nitric oxide, and what are the projected growth trends?
6.Who are the key players in the inhaled nitric oxide market, and what are their respective market shares?
7.What are the major challenges and opportunities facing the inhaled nitric oxide market in the near future?
8.How is the regulatory environment for inhaled nitric oxide evolving, and what impact might this have on the market?
9.What are the key technological developments driving innovation in the inhaled nitric oxide market?
10.How does the cost of inhaled nitric oxide compare to other treatments for the same medical conditions, and what factors influence pricing in this market?
Buy Premium Copy ofInhaled Nitric Oxide Market Growth Report at:
Browse other research published by Allied Market Research:
Body Temperature Monitoring - Market
Indwelling Catheters Market -
Infection Control Market -
Smart Home Healthcare Market -
Cancer Stem Cells Market -
Laboratory Filtration Market -
Sleep Apnea Oral Appliances Market -
U.S. Pain Management Drugs Market-
Intracranial Aneurysm Market -
Microcatheters Market -
David Correa
Allied Analytics LLP
+1-800-792-5285
email us here